M4MM

Optimi Ships Psilocybin to the UK for Phase 2 Trial

VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...

Trulieve Announces Share Buyback Program

TALLAHASSEE – Trulieve Cannabis Corp. announced that its Board of Directors has authorized a share repurchase program, allowing the company to buy back up to the lesser of $50 million in aggregate value or 8,495,038 ...

Subscribe To Our Newsletter